Previous close | 160.65 |
Open | 160.30 |
Bid | 160.50 x 1000 |
Ask | 160.90 x 1400 |
Day's range | 159.11 - 161.41 |
52-week range | 109.16 - 161.95 |
Volume | 7,630,813 |
Avg. volume | 7,394,343 |
Market cap | 421.996B |
Beta (5Y monthly) | 0.70 |
PE ratio (TTM) | 25.20 |
EPS (TTM) | 6.36 |
Earnings date | 26 Jan 2021 |
Forward dividend & yield | 4.04 (2.52%) |
Ex-dividend date | 22 Feb 2021 |
1y target est | 167.59 |
All of the future leaders in this list — who, once they identify as LGBT+, can be in any position in a company, can be any nationality, and based in any country — were nominated by peers and colleagues, or put themselves forward.
J&J (JNJ) gets accelerated approval for a new indication of Darzalex Faspro in combination with bortezomib, cyclophosphamide and dexamethasone for treating amyloidosis patients.
President-elect Joe Biden released a $1.9 trillion COVID-19 response plan on Thursday evening, setting goals for his first 100 days in office, including a call for 100 million vaccinations by then.